Literature DB >> 24415403

Laboratory tests during direct oral anticoagulant treatment.

Sophie Testa1, Oriana Paoletti.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24415403     DOI: 10.1007/s11739-013-1042-7

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

Review 1.  [Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013].

Authors:  G Pernod; P Albaladejo; A Godier; C M Samama; S Susen; Y Gruel; N Blais; P Fontana; A Cohen; J V Llau; N Rosencher; J F Schved; E de Maistre; M M Samama; P Mismetti; P Sié
Journal:  Ann Fr Anesth Reanim       Date:  2013-08-30

2.  Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL1).

Authors:  Armando Tripodi; Giancarlo Di Iorio; Giuseppe Lippi; Sophie Testa; Cesare Manotti
Journal:  Clin Chem Lab Med       Date:  2012-12       Impact factor: 3.694

3.  Laboratory tests during direct oral anticoagulant treatment? No.

Authors:  Giovanni Di Minno; Elena Ricciardi; Antonella Scalera
Journal:  Intern Emerg Med       Date:  2013-05-21       Impact factor: 3.397

4.  Laboratory tests during direct oral anticoagulant treatment? Yes.

Authors:  Vittorio Pengo
Journal:  Intern Emerg Med       Date:  2013-05-21       Impact factor: 3.397

Review 5.  Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban.

Authors:  Inna Y Gong; Richard B Kim
Journal:  Can J Cardiol       Date:  2013-07       Impact factor: 5.223

  5 in total
  1 in total

1.  Laboratory tests during direct oral anticoagulant treatment? Authors' reply.

Authors:  Giovanni Di Minno; Elena Ricciardi; Antonella Scalera
Journal:  Intern Emerg Med       Date:  2015-06-19       Impact factor: 3.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.